{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T21:32:43Z","timestamp":1769981563023,"version":"3.49.0"},"reference-count":129,"publisher":"Begell House","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Crit Rev Oncog"],"published-print":{"date-parts":[[2025]]},"abstract":"<p>Pre-B-cell leukemia homeobox 3 (PBX3) is a homeobox transcription factor that belongs to the pre-B-cell leukemia homeobox family. Studies have revealed that PBX3 plays crucial roles in tumor progression and metastasis. PBX3 upregulation has been linked to various tumors, where it contributes to cell growth and development. One of its primary functions in tumor biology is promoting cell proliferation by modulating the cell cycle. Moreover, PBX3 inhibits apoptotic pathways, allowing tumor cells to survive and resist treatment. In addition to its role in survival, PBX3 is involved in epithelial-mesenchymal transition (EMT) and enhances the invasive potential, contributing to tumor spread. It also exerts its effects through interactions with other transcription factors, including homeobox proteins, and by forming complexes that bind to specific DNA sequences, activating or repressing target gene expression. Given its central role in tumor progression, PBX3 presents a promising diagnostic and therapeutic target. The development of PBX3-specific therapies, such as proteolysis-targeting chimeras (PROTACs), could provide a novel approach for tumor treatment. While challenges remain in achieving selectivity and minimizing off-target effects, PBX3-targeted therapies have the potential to improve patient outcomes, particularly for tumors characterized by PBX3 overexpression.<\/p>","DOI":"10.1615\/critrevoncog.2025060912","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T17:05:55Z","timestamp":1761671155000},"page":"33-48","source":"Crossref","is-referenced-by-count":0,"title":["Review Article: Decoding the Role of PBX3 in Cancer: Molecular Mechanisms and Therapeutic Strategies"],"prefix":"10.1615","volume":"30","author":[{"given":"Samavia","family":"Jaan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivi","family":"Kasim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shourong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"613","reference":[{"key":"2"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Monica K, Galili N, Nourse J, Saltman D, Cleary ML. PBX2 and PBX3, new homeobox genes with extensive homology to the human proto-oncogene PBX1. Mol Cell Biol. 1991;11:6149-57.","DOI":"10.1128\/MCB.11.12.6149"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Mann RS, Chan SK. Extra specificity from extradenticle: The partnership between HOX and PBX\/EXD homeodomain proteins. Trends Genet. 1996;12:258-62.","DOI":"10.1016\/0168-9525(96)10026-3"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Pan MM, Zhang QY, Wang YY, Liu P, Ren RB, Huang JY, Chen LT, Xi XD, Chen Z, Chen SJ. Human NUP98-IQCG fusion protein induces acute myelomonocytic leukemia in mice by dysregulating the Hox\/Pbx3 pathway. Leukemia. 2016;30:1590-3.","DOI":"10.1038\/leu.2015.347"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Neuteboom ST, Murre C. Pbx raises the DNA binding specificity but not the selectivity of antennapedia Hox proteins. Mol Cell Biol. 1997;17:4696-706.","DOI":"10.1128\/MCB.17.8.4696"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Pilz A, Prohaska R, Peters J, Abbott C. Genetic linkage analysis of the Ak1, Col5a1, Epb7.2, Fpgs, Grp78, Pbx3, and Notch1 genes in the region of mouse chromosome 2 homologous to human chromosome 9q. Genomics. 1994;21:104-9.","DOI":"10.1006\/geno.1994.1230"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Bugide S, David D, Nair A, Kannan N, Samanthapudi VS, Prabhakar J, Manavathi B. Hematopoietic PBX-interacting protein (HPIP) is over expressed in breast infiltrative ductal carcinoma and regulates cell adhesion and migration through modulation of focal adhesion dynamics. Oncogene. 2015;34:4601-12.","DOI":"10.1038\/onc.2014.389"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Novak RL, Harper DP, Caudell D, Slape C, Beachy SH, Aplan PD. Gene expression profiling and candidate gene resequencing identifies pathways and mutations important for malignant transformation caused by leukemogenic fusion genes. Exp Hematol. 2012;40:1016-27.","DOI":"10.1016\/j.exphem.2012.08.001"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Wang GG, Pasillas MP, Kamps MP. Meis1 programs transcription of FLT3 and cancer stem cell character, using a mechanism that requires interaction with Pbx and a novel function of the Meis1 C-terminus. Blood. 2005;106:254-64.","DOI":"10.1182\/blood-2004-12-4664"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Li H, Wang J, Xu F, Wang L, Sun G, Wang J, Yang Y. By downregulating PBX3, miR-526b suppresses the epithelial-mesenchymal transition process in cervical cancer cells. Future Oncol. 2019;15:1577-91.","DOI":"10.2217\/fon-2018-0575"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Blasi F, Bruckmann C. MEIS1 in hematopoiesis and cancer. How MEIS1-PBX interaction can be used in therapy. J Dev Biol. 2021;9:44.","DOI":"10.3390\/jdb9040044"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Windels ML, Cordier F, Van Dorpe J, Ferdinande L, Creytens D. PHOX2B: A diagnostic cornerstone in neurocristopathies and neuroblastomas. J Clin Pathol. 2024;77:378-82.","DOI":"10.1136\/jcp-2023-209047"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Choe SK, Lu P, Nakamura M, Lee J, Sagerstr\u00f6m CG. Meis cofactors control HDAC and CBP accessibility at Hox-regulated promoters during zebrafish embryogenesis. Dev Cell. 2009;17:561-7.","DOI":"10.1016\/j.devcel.2009.08.007"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Sarkar D, Leung EY, Baguley BC, Finlay GJ, Askarian-Amiri ME. Epigenetic regulation in human melanoma: Past and future. Epigenetics. 2015;10:103-21.","DOI":"10.1080\/15592294.2014.1003746"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Xiao S, Song B. LncRNA HOXA-AS2 promotes the progression of prostate cancer via targeting miR-509-3p\/PBX3 axis. Biosci Rep. 2020;40(8):BSR20193287.","DOI":"10.1042\/BSR20193287"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Han HB, Gu J, Zuo HJ, Chen ZG, Zhao W, Li M, Ji DB, Lu YY, Zhang ZQ. Let-7c functions as a metastasis suppressor by targeting MMP11 and PBX3 in colorectal cancer. J Pathol. 2012;226:544-55.","DOI":"10.1002\/path.3014"},{"key":"18","unstructured":"Cheng B, Zhang Y, Wu ZW, Cui ZC, Li WL. MiR-144 inhibits colorectal cancer cell migration and invasion by regulating PBX3. Eur Rev Med Pharmacol Sci. 2020;24:9361-9."},{"key":"19","unstructured":"Zhao J, Meng R, Yao Q, Wang H, Niu J, Cui YU, Chen S, Bai Y. Long non-coding RNA HEIH promotes breast cancer development via negative modulation of microRNA-200b. Pharmazie. 2019;74:471-6."},{"key":"20","doi-asserted-by":"crossref","unstructured":"Zheng X, Xiao H, Liu X, Huang T, Deng C. Exosomal circKIAA1797 regulates cell progression and glycolysis by targeting miR-4429\/PBX3 pathway in gastric cancer. Biochem Genet. 2024;62:1762-78.","DOI":"10.1007\/s10528-023-10529-z"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Wu J, Gong P, Jiang Z. Knockdown of hsa_circ_0043691 restrains the progression of gastric cancer by decoying miR-1294 to target pre-leukemia transcription factor 3. J Clin Lab Anal. 2022;36:e24733.","DOI":"10.1002\/jcla.24733"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Wang D, You D, Pan Y, Liu P. Downregulation of lncRNA-HEIH curbs esophageal squamous cell carcinoma progression by modulating miR-4458\/PBX3. Thorac Cancer. 2020;11:1963-71.","DOI":"10.1111\/1759-7714.13489"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Lu Y, Wu D, Wang J, Li Y, Chai X, Kang Q. miR-320a regulates cell proliferation and apoptosis in multiple myeloma by targeting pre-B-cell leukemia transcription factor 3. Biochem Biophys Res Commun. 2016;473:1315-20.","DOI":"10.1016\/j.bbrc.2016.04.069"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Chen G, Xie Y. miR-495 inhibits proliferation, migration, and invasion and induces apoptosis via inhibiting PBX3 in melanoma cells. Onco Targets Ther. 2018;11:1909-20.","DOI":"10.2147\/OTT.S152362"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Yan T, Wang X, Zhou D, Qiu H, Zhang J, Yang W. Circ_0003489 facilitates multiple myeloma progression by targeting miR-433-3p\/PBX3 axis. Hematology. 2022;27:951-9.","DOI":"10.1080\/16078454.2022.2109554"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Li Z, Huang H, Li Y, Jiang X, Chen P, Arnovitz S, Radmacher MD, Maharry K, Elkahloun A, Yang X, He C, He M, Zhang Z, Dohner K, Neilly MB, Price C, Lussier YA, Zhang Y, Larson RA, Le Beau MM, Caligiuri MA, Bullinger L, Valk PJ, Delwel R, Lowenberg B, Liu PP, Marcucci G, Bloomfield CD, Rowley JD, Chen J. Up-regulation of a HOXA-PBX3 homeobox-gene signature following down-regulation of miR-181 is associated with adverse prognosis in patients with cytogenetically abnormal AML. Blood. 2012;119:2314-24.","DOI":"10.1182\/blood-2011-10-386235"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Fu L, Huo J, Fitrat H, Kong Y, Zhang L, Shang C, Li G, Ji F, Fu X, Qiu X. CircNRIP1 exerts oncogenic functions in papillary thyroid carcinoma by sponging miR-653-5p and regulating PBX3 expression. J Oncol. 2022;2022:2081501.","DOI":"10.1155\/2022\/2081501"},{"key":"28","unstructured":"Li XF, Hu DM, Zhao YX, Zhang L, Jin Y. Knockdown of lncRNA HCG11 suppresses cell progression in ovarian cancer by modulating miR-144-3p\/PBX3. Eur Rev Med Pharmacol Sci. 2020;24:11032-40."},{"key":"29","doi-asserted-by":"crossref","unstructured":"Zhao X, Song X, Zhao Y. circNBPF10\/miR-224 axis regulates PBX3 to promote the malignant progression of lung cancer. J Oncol. 2022;2022:2832920.","DOI":"10.1155\/2022\/2832920"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Wang M, Lv G, Jiang C, Xie S, Wang G. miR-302a inhibits human HepG2 and SMMC-7721 cells proliferation and promotes apoptosis by targeting MAP3K2 and PBX3. Sci Rep. 2019;9:2032.","DOI":"10.1038\/s41598-018-38435-0"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Wu J, Meng X, Jia Y, Chai J, Wang J, Xue X, Dang T. Long non-coding RNA HNF1A-AS1 upregulates OTX1 to enhance angiogenesis in colon cancer via the binding of transcription factor PBX3. Exp Cell Res. 2020;393:112025.","DOI":"10.1016\/j.yexcr.2020.112025"},{"key":"32","unstructured":"Zhang Y, Shi J, Luo J, Liu C, Zhu L. Regulatory mechanisms and potential medical applications of HNF1A-AS1 in cancers. Am J Transl Res. 2022;14:4154-68."},{"key":"33","doi-asserted-by":"crossref","unstructured":"Li Y, Liu L, Lv Y, Zhang Y, Zhang L, Yu H, Tian W, Zhang Z, Cui S. Silencing long non-coding RNA HNF1A-AS1 inhibits growth and resistance to TAM of breast cancer cells via the microRNA-363\/SERTAD3 axis. J Drug Target. 2021;29:742-53.","DOI":"10.1080\/1061186X.2021.1878362"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Ullrich M, Weber M, Post AM, Popp S, Grein J, Zechner M, Guerrero Gonz\u00e1lez H, Kreis A, Schmitt AG, \u00dcceyler N, Lesch KP, Schuh K. OCD-like behavior is caused by dysfunction of thalamo-amygdala circuits and upregulated TrkB\/ERK-MAPK signaling as a result of SPRED2 deficiency. Mol Psych. 2018;23:444-58.","DOI":"10.1038\/mp.2016.232"},{"key":"35","doi-asserted-by":"crossref","unstructured":"Ullrich M, A\u00dfmus B, Augustin AM, H\u00e4bich H, Abesser M, Martin Machado J, Werner F, Erkens R, Arias-Loza AP, Umbenhauer S, Wagner H, Benz PM, Unger A, Linke WA, Frantz S, Baba HA, Kuhn M, Schuh K. SPRED2 deficiency elicits cardiac arrhythmias and premature death via impaired autophagy. J Mol Cell Cardiol. 2019;129:13-26.","DOI":"10.1016\/j.yjmcc.2019.01.023"},{"key":"36","unstructured":"Yang XL, Hao YJ, Wang B, Gu XL, Wang XX, Sun JF. Long noncoding RNA NORAD promotes the progression of retinoblastoma by sponging miR-136-5p\/PBX3 axis. Eur Rev Med Pharmacol Sci. 2020;24:1278-87."},{"key":"37","doi-asserted-by":"crossref","unstructured":"Lu Y, Li L, Li L, Wu G, Liu G. Circular RNA circHECTD1 prevents Diosbulbin-B-sensitivity via miR-137\/PBX3 axis in gastric cancer. Cancer Cell Int. 2021;21:264.","DOI":"10.1186\/s12935-021-01957-1"},{"key":"38","doi-asserted-by":"crossref","unstructured":"Liu Y, Song J, Zhang H, Liao Z, Liu F, Su C, Wang W, Han M, Zhang L, Zhu H, Zhang Z, Liang H, Zhang L, Zhang B, Chen X. EIF4A3-induced circTOLLIP promotes the progression of hepatocellular carcinoma via the miR-516a-5p\/PBX3\/EMT pathway. J Exp Clin Cancer Res. 2022;41:164.","DOI":"10.1186\/s13046-022-02378-2"},{"key":"39","doi-asserted-by":"crossref","unstructured":"Shen LY, Zhou T, Du YB, Shi Q, Chen KN. Targeting HOX\/PBX dimer formation as a potential therapeutic option in esophageal squamous cell carcinoma. Cancer Sci. 2019;110:1735-45.","DOI":"10.1111\/cas.13993"},{"key":"40","doi-asserted-by":"crossref","unstructured":"Zhou Q, Lei C, Cui F, Chen H, Cao X. Circ-ATIC regulates esophageal squamous cell carcinoma growth and metastasis through miR-1294\/PBX3 pathway. Heliyon. 2023;9:e12916.","DOI":"10.1016\/j.heliyon.2023.e12916"},{"key":"41","doi-asserted-by":"crossref","unstructured":"Thorne RM, Milne TA. Dangerous liaisons: Cooperation between Pbx3, Meis1 and Hoxa9 in leukemia. Haematologica. 2015;100:850-3.","DOI":"10.3324\/haematol.2015.129932"},{"key":"42","doi-asserted-by":"crossref","unstructured":"Bobola N, Sagerstr\u00f6m CG. TALE transcription factors: Cofactors no more. Semin Cell Dev Biol. 2024;152-3:76-84.","DOI":"10.1016\/j.semcdb.2022.11.015"},{"key":"43","doi-asserted-by":"crossref","unstructured":"Capellini TD, Zappavigna V, Selleri L. Pbx homeodomain proteins: TALEnted regulators of limb patterning and outgrowth. Dev Dyn. 2011;240:1063-86.","DOI":"10.1002\/dvdy.22605"},{"key":"44","doi-asserted-by":"crossref","unstructured":"Schulte D, Geerts D. MEIS transcription factors in development and disease. Development. 2019;146:dev174706.","DOI":"10.1242\/dev.174706"},{"key":"45","doi-asserted-by":"crossref","unstructured":"Dickson GJ, Liberante FG, Kettyle LM, O'Hagan KA, Finnegan DP, Bullinger L, Geerts D, McMullin MF, Lappin TR, Mills KI, Thompson A. HOXA\/PBX3 knockdown impairs growth and sensitizes cytogenetically normal acute myeloid leukemia cells to chemotherapy. Haematologica. 2013;98:1216-25.","DOI":"10.3324\/haematol.2012.079012"},{"key":"46","doi-asserted-by":"crossref","unstructured":"Mok CH, Hu D, Losa M, Risolino M, Selleri L, Marcucio RS. PBX1 and PBX3 transcription factors regulate SHH expression in the frontonasal ectodermal zone through complementary mechanisms. PLoS Genet. 2025;21:e1011315.","DOI":"10.1371\/journal.pgen.1011315"},{"key":"47","doi-asserted-by":"crossref","unstructured":"Losa M, Risolino M, Li B, Hart J, Quintana L, Grishina I, Yang H, Choi IF, Lewicki P, Khan S, Aho R, Feenstra J, Vincent CT, Brown AMC, Ferretti E, Williams T, Selleri L. Face morphogenesis is promoted by Pbx-dependent EMT via regulation of Snail1 during frontonasal prominence fusion. Development. 2018;145:dev157628.","DOI":"10.1242\/dev.157628"},{"key":"48","doi-asserted-by":"crossref","unstructured":"Khumukcham SS, Samanthapudi VSK, Penugurti V, Kumari A, Kesavan PS, Velatooru LR, Kotla SR, Mazumder A, Manavathi B. Hematopoietic PBX-interacting protein is a substrate and an inhibitor of the APC\/C-Cdc20 complex and regulates mitosis by stabilizing cyclin B1. J Biol Chem. 2019;294:10236-52.","DOI":"10.1074\/jbc.RA118.006733"},{"key":"49","doi-asserted-by":"crossref","unstructured":"Qin P, Haberbusch JM, Soprano KJ, Soprano DR. Retinoic acid regulates the expression of PBX1, PBX2, and PBX3 in P19 cells both transcriptionally and post-translationally. J Cell Biochem. 2004;92:147\u00e2\u0080\u009363.","DOI":"10.1002\/jcb.20057"},{"key":"50","doi-asserted-by":"crossref","unstructured":"Welsh IC, Hart J, Brown JM, Hansen K, Rocha Marques M, Aho RJ, Grishina I, Hurtado R, Herzlinger D, Ferretti E, Garcia-Garcia MJ, Selleri L. Pbx loss in cranial neural crest, unlike in epithelium, results in cleft palate only and a broader midface. J Anat. 2018;233:222-42.","DOI":"10.1111\/joa.12821"},{"key":"51","doi-asserted-by":"crossref","unstructured":"Longobardi E, Penkov D, Mateos D, De Florian G, Torres M, Blasi F. Biochemistry of the tale transcription factors PREP, MEIS, and PBX in vertebrates. Dev Dyn. 2014;243:59-75.","DOI":"10.1002\/dvdy.24016"},{"key":"52","doi-asserted-by":"crossref","unstructured":"Maves L, Waskiewicz AJ, Paul B, Cao Y, Tyler A, Moens CB, Tapscott SJ. Pbx homeodomain proteins direct Myod activity to promote fast-muscle differentiation. Development. 2007;134:3371-82.","DOI":"10.1242\/dev.003905"},{"key":"53","doi-asserted-by":"crossref","unstructured":"Elyamany G, Alotaibi S, Alharbi B, Alhafi OA, Aljasem H, Jamil H, Roshan TM, Akhter A, Mansoor A. HOX-PBX Up-regulation predicts favorable prognosis in NPM1-mutated normal cytogenetic AML via WNT signaling. Anticancer Res. 2025;45:2079-89.","DOI":"10.21873\/anticanres.17582"},{"key":"54","doi-asserted-by":"crossref","unstructured":"Maili L, Letra A, Silva R, Buchanan EP, Mulliken JB, Greives MR, Teichgraeber JF, Blackwell SJ, Ummer R, Weber R, Chiquet B, Blanton SH, Hecht JT. PBX-WNTP63-IRF6 pathway in nonsyndromic cleft lip and palate. Birth Defects Res. 2020;112:234-44.","DOI":"10.1002\/bdr2.1630"},{"key":"55","doi-asserted-by":"crossref","unstructured":"Ferretti E, Li B, Zewdu R, Wells V, Hebert JM, Karner C, Anderson MJ, Williams T, Dixon J, Dixon MJ, Depew MJ, Selleri L. A conserved Pbx-Wnt-p63-Irf6 regulatory module controls face morphogenesis by promoting epithelial apoptosis. Dev Cell. 2011;21:627-41.","DOI":"10.1016\/j.devcel.2011.08.005"},{"key":"56","doi-asserted-by":"crossref","unstructured":"Shi S, Zhao J, Wang J, Mi D, Ma Z. HPIP silencing inhibits TGF-b1-induced EMT in lung cancer cells. Int J Mol Med. 2017;39:479-83.","DOI":"10.3892\/ijmm.2017.2851"},{"key":"57","doi-asserted-by":"crossref","unstructured":"Zhang GY, Liu AH, Li GM, Wang JR. HPIP silencing prevents epithelial-mesenchymal transition induced by TGF-b1 in human ovarian cancer cells. Oncol Res. 2016;24:33-9.","DOI":"10.3727\/096504016X14575597858654"},{"key":"58","doi-asserted-by":"crossref","unstructured":"Milech N, Kees UR, Watt PM. Novel alternative PBX3 isoforms in leukemia cells with distinct interaction specificities. Genes Chromosomes Cancer. 2001;32:275-80.","DOI":"10.1002\/gcc.1190"},{"key":"59","doi-asserted-by":"crossref","unstructured":"Macheret M, Halazonetis TD. DNA replication stress as a hallmark of cancer. Annu Rev Pathol. 2015;10:425-48.","DOI":"10.1146\/annurev-pathol-012414-040424"},{"key":"60","doi-asserted-by":"crossref","unstructured":"Alberghina L. The Warburg effect explained: Integration of enhanced glycolysis with heterogeneous mitochondria to promote cancer cell proliferation. Int J Mol Sci. 2023;24:15787.","DOI":"10.3390\/ijms242115787"},{"key":"61","doi-asserted-by":"crossref","unstructured":"Pavlova NN, Zhu J, Thompson CB. The hallmarks of cancer metabolism: Still emerging. Cell Metab. 2022;34:355-77.","DOI":"10.1016\/j.cmet.2022.01.007"},{"key":"62","doi-asserted-by":"crossref","unstructured":"Kroemer G, Pouyssegur J. Tumor cell metabolism: Cancer's Achilles' heel. Cancer Cell. 2008;13:472-82.","DOI":"10.1016\/j.ccr.2008.05.005"},{"key":"63","doi-asserted-by":"crossref","unstructured":"Alharbi RA, Pandha HS, Simpson GR, Pettengell R, Poterlowicz K, Thompson A, Harrington K, El-Tanani M, Morgan R. Inhibition of HOX\/PBX dimer formation leads to necroptosis in acute myeloid leukemia cells. Oncotarget. 2017;8:89566-79.","DOI":"10.18632\/oncotarget.20023"},{"key":"64","doi-asserted-by":"crossref","unstructured":"MacKinnon WF, Carter MD, Bridge JA, Tremaine RD, Walsh NMG. EWSR1-PBX3 gene fusion in cutaneous syncytial myoepithelioma. J Cutan Pathol. 2019;46:421-4.","DOI":"10.1111\/cup.13450"},{"key":"65","doi-asserted-by":"crossref","unstructured":"Panagopoulos I, Gorunova L, Bjerkehagen B, Heim S. Fusion of the genes EWSR1 and PBX3 in retroperitoneal leiomyoma with t(9;22)(q33;q12). PLoS One. 2015;10:e0124288.","DOI":"10.1371\/journal.pone.0124288"},{"key":"66","doi-asserted-by":"crossref","unstructured":"Haglund C, Zemmler M, Tsagkozis P, Haglund de Flon F. An intraosseous myoepithelial carcinoma with a EWSR1::PBX3 fusion. Genes Chromosomes Cancer. 2023;62:607-10.","DOI":"10.1002\/gcc.23148"},{"key":"67","doi-asserted-by":"crossref","unstructured":"Ramberg H, Alshbib A, Berge V, Svindland A, Task\u00e9n KA. Regulation of PBX3 expression by androgen and Let-7d in prostate cancer. Mol Cancer. 2011;10:50.","DOI":"10.1186\/1476-4598-10-50"},{"key":"68","doi-asserted-by":"crossref","unstructured":"Li Z, Chen P, Su R, Hu C, Li Y, Elkahloun AG, Zuo Z, Gurbuxani S, Arnovitz S, Weng H, Wang Y, Li S, Huang H, Neilly MB, Wang GG, Jiang X, Liu PP, Jin J, Chen J. PBX3 and MEIS1 cooperate in hematopoietic cells to drive acute myeloid leukemias characterized by a core transcriptome of the MLL-rearranged disease. Cancer Res. 2016;76:619-29.","DOI":"10.1158\/0008-5472.CAN-15-1566"},{"key":"69","doi-asserted-by":"crossref","unstructured":"Han H, Du Y, Zhao W, Li S, Chen D, Zhang J, Liu J, Suo Z, Bian X, Xing B, Zhang Z. PBX3 is targeted by multiple miRNAs and is essential for liver tumour-initiating cells. Nat Commun. 2015;6:8271.","DOI":"10.1038\/ncomms9271"},{"key":"70","doi-asserted-by":"crossref","unstructured":"Pang ZY, Wei YT, Shang MY, Li S, Li Y, Jin QX, Liao ZX, Cui MK, Liu XY, Zhang Q. Leptin-elicited PBX3 confers letrozole resistance in breast cancer. Endocr Relat Cancer. 2021;28:173-89.","DOI":"10.1530\/ERC-20-0328"},{"key":"71","doi-asserted-by":"crossref","unstructured":"Wang D, Jin X, Lei M, Jiang Y, Liu Y, Yu F, Guo Y, Han B, Yang Y, Sun W, Liu Y, Zeng G, Liu F, Hu J, Chen X. USF1-ATRAP-PBX3 axis promote breast cancer glycolysis and malignant phenotype by activating AKT\/mTOR signaling. Int J Biol Sci. 2022;18:2452-71.","DOI":"10.7150\/ijbs.69134"},{"key":"72","doi-asserted-by":"crossref","unstructured":"Oh KT, Koo KC, Chung BH, Lee KS. Comparison of prostate cancer detection rates of various prostate biopsy methods for patients with prostate-specific antigen levels of < 10.0 ng\/mL in real-world practice. Investig Clin Urol. 2020;61:28-34.","DOI":"10.4111\/icu.2020.61.1.28"},{"key":"73","doi-asserted-by":"crossref","unstructured":"Luo X, Wei M, Li W, Zhao H, Kasim V, Wu S. PBX3 promotes pentose phosphate pathway and colorectal cancer progression by enhancing G6PD expression. Int J Biol Sci. 2023;19:4525-38.","DOI":"10.7150\/ijbs.86279"},{"key":"74","doi-asserted-by":"crossref","unstructured":"Feng Y, Xu X, Zhang Y, Ding J, Wang Y, Zhang X, Wu Z, Kang L, Liang Y, Zhou L, Song S, Zhao K, Ye Q. HPIP is upregulated in colorectal cancer and regulates colorectal cancer cell proliferation, apoptosis and invasion. Sci Rep. 2015;5:9429.","DOI":"10.1038\/srep09429"},{"key":"75","doi-asserted-by":"crossref","unstructured":"Zhang X, Qiu L, Zhang L, Li W, Xiang D, Wang J, Wu S, Kasim V. PBX3-HMGCR axis promotes hepatocellular carcinoma progression through enhancing de novo cholesterol biosynthesis. Int J Mol Sci. 2025;26:5210.","DOI":"10.3390\/ijms26115210"},{"key":"76","doi-asserted-by":"crossref","unstructured":"Wang S, Li C, Wang W, Xing C. PBX3 promotes gastric cancer invasion and metastasis by inducing epithelial-mesenchymal transition. Oncol Lett. 2016;12:3485-91.","DOI":"10.3892\/ol.2016.5305"},{"key":"77","doi-asserted-by":"crossref","unstructured":"Zhang H, Shi X, Ge Z, Wang Z, Gao Y, Gao G, Xu W, Qu X. PBX3-activated DLG1-AS1 can promote the proliferation, invasion, and migration of TNBC cells by sponging miR-16-5p. Mol Ther Oncolytics. 2022;25:201-10.","DOI":"10.1016\/j.omto.2021.12.023"},{"key":"78","doi-asserted-by":"crossref","unstructured":"Xu J, Li Y, Wang F, Wang X, Cheng B, Ye F, Xie X, Zhou C, Lu W. Suppressed miR-424 expression via upregulation of target gene Chk1 contributes to the progression of cervical cancer. Oncogene. 2013;32:976-87.","DOI":"10.1038\/onc.2012.121"},{"key":"79","doi-asserted-by":"crossref","unstructured":"Lamprecht S, Kaller M, Schmidt EM, Blaj C, Schiergens TS, Engel J, Jung A, Hermeking H, Gr\u00fcnewald TGP, Kirchner T, Horst D. PBX3 is part of an EMT regulatory network and indicates poor outcome in colorectal cancer. Clin Cancer Res. 2018;24:1974-86.","DOI":"10.1158\/1078-0432.CCR-17-2572"},{"key":"80","doi-asserted-by":"crossref","unstructured":"Rangachari M, Zhu C, Sakuishi K, Xiao S, Karman J, Chen A, Angin M, Wakeham A, Greenfield EA, Sobel RA, Okada H, McKinnon PJ, Mak TW, Addo MM, Anderson AC, Kuchroo VK. Bat3 promotes T cell responses and autoimmunity by repressing Tim-3\u00e2\u0080\u0093mediated cell death and exhaustion. Nat Med. 2012;18:1394-400.","DOI":"10.1038\/nm.2871"},{"key":"81","doi-asserted-by":"crossref","unstructured":"Zhang Z, Huang A, Zhang A, Zhou C. HuR promotes breast cancer cell proliferation and survival via binding to CDK3 mRNA. Biomed Pharmacother. 2017;91:788-95.","DOI":"10.1016\/j.biopha.2017.04.063"},{"key":"82","doi-asserted-by":"crossref","unstructured":"Macagno N, Kervarrec T, Thanguturi S, Sohier P, Pissaloux D, Mescam L, Jullie ML, Frouin E, Osio A, Faisant M, Le Loarer F, Cribier B, Calonje E, Luna EVE, Massi D, Goto K, Nishida H, Paindavoine S, Houlier A, Tantot J, Benzerdjeb N, Tirode F, De la Fouchardi\u00e8re A, Battistella M. SOX10-internal tandem duplications and PLAG1 or HMGA2 fusions segregate eccrine-type and apocrine-type cutaneous mixed tumors. Mod Pathol. 2024;37:100430.","DOI":"10.1016\/j.modpat.2024.100430"},{"key":"83","doi-asserted-by":"crossref","unstructured":"Zhang Y, Guo H, Zhang H. SNHG10\/DDX54\/PBX3 feedback loop contributes to gastric cancer cell growth. Dig Dis Sci. 2021;66:1875-84.","DOI":"10.1007\/s10620-020-06488-9"},{"key":"84","doi-asserted-by":"crossref","unstructured":"Zhou H, Rao Y, Sun Q, Liu Y, Zhou X, Chen Y, Chen J. MiR-4458\/human antigen R (HuR) modulates PBX3 mRNA stability in melanoma tumorigenesis. Arch Dermatol Res. 2020;312:665-73.","DOI":"10.1007\/s00403-020-02051-8"},{"key":"85","doi-asserted-by":"crossref","unstructured":"Wang SC, Chai DS, Chen CB, Wang ZY, Wang L. HPIP promotes thyroid cancer cell growth, migration and EMT through activating PI3K\/AKT signaling pathway. Biomed Pharmacother. 2015;75:33-9.","DOI":"10.1016\/j.biopha.2015.08.027"},{"key":"86","doi-asserted-by":"crossref","unstructured":"Chen Y, Zhao R, Zhao Q, Shao Y, Zhang S. Knockdown of HPIP inhibits the proliferation and invasion of head-and-neck squamous cell carcinoma cells by regulating PI3K\/Akt signaling pathway. Oncol Res. 2016;24:153-60.","DOI":"10.3727\/096504016X14612603423476"},{"key":"87","doi-asserted-by":"crossref","unstructured":"Li H, Sun G, Liu C, Wang J, Jing R, Wang J, Zhao X, Xu X, Yang Y. PBX3 is associated with proliferation and poor prognosis in patients with cervical cancer. Onco Targets Ther. 2017;10:5685-94.","DOI":"10.2147\/OTT.S150139"},{"key":"88","doi-asserted-by":"crossref","unstructured":"Yan J, Yang J, Shen H, Gao R, Lv S. Sinomenine regulates circTRPM7-related pathway to inhibit gastric cancer cell growth and metastasis. Chem Biol Drug Des. 2023;102:870-81.","DOI":"10.1111\/cbdd.14297"},{"key":"89","doi-asserted-by":"crossref","unstructured":"Arunachalam E, Rogers W, Simpson GR, M\u00f6ller-Levet C, Bolton G, Ismael M, Smith C, Keegen K, Bagwan I, Brend T, Short SC, Hong B, Otani Y, Kaur B, Annels N, Morgan R, Pandha H. HOX and PBX gene dysregulation as a therapeutic target in glioblastoma multiforme. BMC Cancer. 2022;22:400.","DOI":"10.1186\/s12885-022-09466-8"},{"key":"90","doi-asserted-by":"crossref","unstructured":"Zhang Y, Feng J, Cui J, Yang G, Zhu X. Pre-B cell leukemia transcription factor 3 induces inflammatory responses in human umbilical vein endothelial cells and murine sepsis via acting a competing endogenous RNA for high mobility group box 1 protein. Mol Med Rep. 2018;17:5805-13.","DOI":"10.3892\/mmr.2018.8609"},{"key":"91","doi-asserted-by":"crossref","unstructured":"Zhang W, Zhao C, Zhao J, Zhu Y, Weng X, Chen Q, Sun H, Mi JQ, Li J, Zhu J, Chen Z, Pandolfi PP, Chen S, Yan X, Xu J. Inactivation of PBX3 and HOXA9 by down-regulating H3K79 methylation represses NPM1-mutated leukemic cell survival. Theranostics. 2018;8:4359-71.","DOI":"10.7150\/thno.26900"},{"key":"92","doi-asserted-by":"crossref","unstructured":"Li H, Huang J, Yu S, Li H, Zhou Y, Wu Q. HOXA11-AS induces cisplatin resistance by modulating the microRNA-98\/PBX3 axis in nasopharyngeal carcinoma. Oncol Lett. 2021;21:493.","DOI":"10.3892\/ol.2021.12754"},{"key":"93","doi-asserted-by":"crossref","unstructured":"Ma Y, Zhang H, Li G, Hu J, Liu X, Lin L. LncRNA ANRIL promotes cell growth, migration and invasion of hepatocellular carcinoma cells via sponging miR-144. Anticancer Drugs. 2019;30:1013-21.","DOI":"10.1097\/CAD.0000000000000807"},{"key":"94","doi-asserted-by":"crossref","unstructured":"Li WF, Herkilini A, Tang Y, Huang P, Song GB, Miyagishi M, Kasim V, Wu SR. The transcription factor PBX3 promotes tumor cell growth through transcriptional suppression of the tumor suppressor p53. Acta Pharmacol Sin. 2021;42:1888-99.","DOI":"10.1038\/s41401-020-00599-9"},{"key":"95","doi-asserted-by":"crossref","unstructured":"Platais C, Radhakrishnan R, Niklander Ebensperger S, Morgan R, Lambert DW, Hunter KD. Targeting HOXPBX interactions causes death in oral potentially malignant and squamous carcinoma cells but not normal oral keratinocytes. BMC Cancer. 2018;18:723.","DOI":"10.1186\/s12885-018-4622-0"},{"key":"96","doi-asserted-by":"crossref","unstructured":"G\u0130rg\u0130n B, Karada\u011e-Alpaslan M, Kocaba\u015e F. Oncogenic and tumor suppressor function of MEIS and associated factors. Turk J Biol. 2020;44:328-55.","DOI":"10.3906\/biy-2006-25"},{"key":"97","doi-asserted-by":"crossref","unstructured":"Katoh M, Katoh M. Cross-talk of WNT and FGF signaling pathways at GSK3beta to regulate beta-catenin and SNAIL signaling cascades. Cancer Biol Ther. 2006;5:1059-64.","DOI":"10.4161\/cbt.5.9.3151"},{"key":"98","doi-asserted-by":"crossref","unstructured":"Risolino M, Mandia N, Iavarone F, Dardaei L, Longobardi E, Fernandez S, Talotta F, Bianchi F, Pisati F, Spaggiari L, Harter PN, Mittelbronn M, Schulte D, Incoronato M, Di Fiore PP, Blasi F, Verde P. Transcription factor PREP1 induces EMT and metastasis by controlling the TGF-beta-SMAD3 pathway in non-small cell lung adenocarcinoma. Proc Natl Acad Sci U S A. 2014;111:E3775-84.","DOI":"10.1073\/pnas.1407074111"},{"key":"99","doi-asserted-by":"crossref","unstructured":"Shenoy US, Basavarajappa DS, Kabekkodu SP, Radhakrishnan R. Pan-cancer exploration of oncogenic and clinical impacts revealed that HOXA9 is a diagnostic indicator of tumorigenesis. Clin Exp Med. 2024;24:134.","DOI":"10.1007\/s10238-024-01389-x"},{"key":"100","doi-asserted-by":"crossref","unstructured":"Xu X, Bao Z, Liu Y, Ji J, Liu N. MicroRNA-98 attenuates cell migration and invasion in glioma by directly targeting pre-B cell leukemia homeobox 3. Cell Mol Neurobiol. 2017;37:1359-71.","DOI":"10.1007\/s10571-017-0466-4"},{"key":"101","doi-asserted-by":"crossref","unstructured":"Han HB, Gu J, Ji DB, Li ZW, Zhang Y, Zhao W, Wang LM, Zhang ZQ. PBX3 promotes migration and invasion of colorectal cancer cells via activation of MAPK\/ERK signaling pathway. World J Gastroenterol. 2014;20:18260-70.","DOI":"10.3748\/wjg.v20.i48.18260"},{"key":"102","doi-asserted-by":"crossref","unstructured":"Zewdu R, Risolino M, Barbulescu A, Ramalingam P, Butler JM, Selleri L. Spleen hypoplasia leads to abnormal stress hematopoiesis in mice with loss of Pbx homeoproteins in splenic mesenchyme. J Anat. 2016;229:153-69.","DOI":"10.1111\/joa.12479"},{"key":"103","doi-asserted-by":"crossref","unstructured":"Chao G, Zhang L. Correlation analysis of PBX family with immune invasion and drug sensitivity in colon adenocarcinoma. Heliyon. 2023;9:e17220.","DOI":"10.1016\/j.heliyon.2023.e17220"},{"key":"104","doi-asserted-by":"crossref","unstructured":"Shaker N, Phelps R, Niedt G, Sangueza OP, Youngs J, Lauer S, Pradhan D. Cutaneous syncytial myoepithelioma: An uncommon and distinct variant of cutaneous epithelioid neoplasm. Am J Dermatopathol. 2024;46:377-80.","DOI":"10.1097\/DAD.0000000000002691"},{"key":"105","doi-asserted-by":"crossref","unstructured":"Mahmood MN. Cutaneous syncytial myoepithelioma: A unique variant worth recognizing. Dermatopathology. 2023;10:219-25.","DOI":"10.3390\/dermatopathology10030030"},{"key":"106","doi-asserted-by":"crossref","unstructured":"Jo VY, Antonescu CR, Dickson BC, Swanson D, Zhang L, Fletcher CDM, Demicco EG. Cutaneous syncytial myoepithelioma is characterized by recurrent EWSR1-PBX3 fusions. Am J Surg Pathol. 2019;43:1349-54.","DOI":"10.1097\/PAS.0000000000001286"},{"key":"107","doi-asserted-by":"crossref","unstructured":"Agaram NP, Chen HW, Zhang L, Sung YS, Panicek D, Healey JH, Nielsen GP, Fletcher CD, Antonescu CR. EWSR1-PBX3: A novel gene fusion in myoepithelial tumors. Genes Chromosomes Cancer. 2015;54:63-71.","DOI":"10.1002\/gcc.22216"},{"key":"108","doi-asserted-by":"crossref","unstructured":"Ramberg H, Grytli HH, Nygard S, Wang W, \u00d6gren O, Zhao S, Lovf M, Katz B, Skotheim RI, Bjartell A, Eri LM, Berge V, Svindland A, Task\u00e9n KA. PBX3 is a putative biomarker of aggressive prostate cancer. Int J Cancer. 2016;139:1810-20.","DOI":"10.1002\/ijc.30220"},{"key":"109","doi-asserted-by":"crossref","unstructured":"Chen Q, Yu WY, Zhang HH, Zhang SZ, Fang J, Wu F, Ying HZ, Yu CH. PBX3 Promotes tumor growth and angiogenesis via activation of AT1R\/VEGFR2 pathway in papillary thyroid carcinoma. Biomed Res Int. 2020;2020:8954513.","DOI":"10.1155\/2020\/8954513"},{"key":"110","doi-asserted-by":"crossref","unstructured":"He X, Xu Y, Huang D, Yu Z, Yu J, Xie L, Liu L, Yu Y, Chen C, Wan J, Zhang Y, Zheng J. P2X1 enhances leukemogenesis through PBX3-BCAT1 pathways. Leukemia. 2023;37:265-75.","DOI":"10.1038\/s41375-022-01759-y"},{"key":"111","doi-asserted-by":"crossref","unstructured":"Li D, Yuan Y, Meng C, Lin Z, Zhao M, Shi L, Li M, Ye D, Cai Y, He X, Ye H, Zhou S, Zhou H, Gao S. Low expression of miR-182 caused by DNA hypermethylation accelerates acute lymphocyte leukemia development by targeting PBX3 and BCL2: miR-182 promoter methylation is a predictive marker for hypomethylation agents + BCL2 inhibitor venetoclax. Clin Epigen. 2024;16:48.","DOI":"10.1186\/s13148-024-01658-2"},{"key":"112","doi-asserted-by":"crossref","unstructured":"Feng W, Yang X, Wang L, Wang R, Yang F, Wang H, Liu X, Ren Q, Zhang Y, Zhu X, Zheng G. P2X7 promotes the progression of MLL-AF9 induced acute myeloid leukemia by upregulation of Pbx3. Haematologica. 2021;106:1278-89.","DOI":"10.3324\/haematol.2019.243360"},{"key":"113","doi-asserted-by":"crossref","unstructured":"Wu Y, Zhang Y, Zheng X, Dai F, Lu Y, Dai L, Niu M, Guo H, Li W, Xue X, Bo Y, Guo Y, Qin J, Qin Y, Liu H, Zhang Y, Yang T, Li L, Zhang L, Hou R, Wen S, An C, Li H, Xu W, Gao W. Circular RNA circCORO1C promotes laryngeal squamous cell carcinoma progression by modulating the let-7c-5p\/PBX3 axis. Mol Cancer. 2020;19:99.","DOI":"10.1186\/s12943-020-01215-4"},{"key":"114","doi-asserted-by":"crossref","unstructured":"Huang X, Wang Z, Hou S, Yue C, Li Z, Hu W, Lu H. Long non-coding RNA DSCAM-AS1 promotes pancreatic cancer progression via regulating the miR-136-5p\/PBX3 axis. Bioengineered. 2022;13:4153-65.","DOI":"10.1080\/21655979.2021.2016326"},{"key":"115","doi-asserted-by":"crossref","unstructured":"Hu JE, Bojarski C, Branchi F, Fromm M, Krug SM. Leptin downregulates Angulin-1 in active Crohn's disease via STAT3. Int J Mol Sci. 2020;21:7824.","DOI":"10.3390\/ijms21217824"},{"key":"116","doi-asserted-by":"crossref","unstructured":"Schultz CW, Nevler A. Pyrvinium Pamoate: Past, present, and future as an anti-cancer drug. Biomedicines. 2022;10:3249.","DOI":"10.3390\/biomedicines10123249"},{"key":"117","doi-asserted-by":"crossref","unstructured":"Moll\u00e9 N, Krichevsky S, Kermani P, Silver RT, Ritchie E, Scandura JM. Ruxolitinib can cause weight gain by blocking leptin signaling in the brain via JAK2\/STAT3. Blood. 2020;135:1062-6.","DOI":"10.1182\/blood.2019003050"},{"key":"118","doi-asserted-by":"crossref","unstructured":"Raghav A, Jeong GB. Nanoquercetin and extracellular vesicles as potential anticancer therapeutics in hepatocellular carcinoma. Cells. 2024;13:638.","DOI":"10.3390\/cells13070638"},{"key":"119","doi-asserted-by":"crossref","unstructured":"Zhang C, Featherstone M. A zebrafish hox gene acts before gastrulation to specify the hemangioblast. Genesis. 2020;58:e23363.","DOI":"10.1002\/dvg.23363"},{"key":"120","doi-asserted-by":"crossref","unstructured":"Xu X, Bao Z, Liu Y, Jiang K, Zhi T, Wang D, Fan L, Liu N, Ji J. PBX3\/MEK\/ERK1\/2\/LIN28\/let-7b positive feedback loop enhances mesenchymal phenotype to promote glioblastoma migration and invasion. J Exp Clin Cancer Res. 2018;37:158.","DOI":"10.1186\/s13046-018-0841-0"},{"key":"121","doi-asserted-by":"crossref","unstructured":"Pan C, Bai X, Li N, Zheng N, Si Y, Zhao Y. PBX3 as a biomarker for the early diagnosis and prediction of prognosis of glioma. PLoS One. 2024;19:e0293647.","DOI":"10.1371\/journal.pone.0293647"},{"key":"122","doi-asserted-by":"crossref","unstructured":"Tomczak K, Czerwi\u00c5\u0084ska P, Wiznerowicz M. The Cancer Genome Atlas (TCGA): An immeasurable source of knowledge. Contemp Oncol. 2015;19:A68-77.","DOI":"10.5114\/wo.2014.47136"},{"key":"123","doi-asserted-by":"crossref","unstructured":"Morgan R, Pandha HS. PBX3 in cancer. Cancers. 2020;12:431.","DOI":"10.3390\/cancers12020431"},{"key":"124","doi-asserted-by":"crossref","unstructured":"Jin Y, Chen X, Gao ZY, Liu K, Hou Y, Zheng J. The role of miR-320a and IL-1Beta in human chondrocyte degradation. Bone Joint Res. 2017;6:196-203.","DOI":"10.1302\/2046-3758.64.BJR-2016-0224.R1"},{"key":"125","doi-asserted-by":"crossref","unstructured":"Williams AT, Shrine N, Naghra-van Gijzel H, Betts JC, Chen J, Hessel EM, John C, Packer R, Reeve NF, Yeo AJ, Abner E, Asvold BO, Auvinen J, Bartz TM, Bradford Y, Brumpton B, Campbell A, Cho MH, Chu S, Crosslin DR, Feng Q, Esko T, Gharib SA, Hayward C, Hebbring S, Hveem K, J\u00e4rvelin MR, Jarvik GP, Landis SH, Larson EB, Liu J, Loos RJF, Luo Y, Moscati A, Mullerova H, Namjou B, Porteous DJ, Quint JK, Ritchie MD, Sliz E, Stanaway IB, Thomas L, Wilson JF, Hall IP, Wain LV, Michalovich D, Tobin MD. Genome-wide association study of susceptibility to hospitalised respiratory infections. Wellcome Open Res. 2021;6:290.","DOI":"10.12688\/wellcomeopenres.17230.2"},{"key":"126","doi-asserted-by":"crossref","unstructured":"Ma YY, Zhang Y, Mou XZ, Liu ZC, Ru GQ, Li E. High level of homeobox A9 and PBX homeobox 3 expression in gastric cancer correlates with poor prognosis. Oncol Lett. 2017;14:5883-9.","DOI":"10.3892\/ol.2017.6937"},{"key":"127","doi-asserted-by":"crossref","unstructured":"Zhang Y, Xie Y, Lu W, Xu S, Wang X, Zhou W, Zhang Y, Ding X, Zhao S. Identification of resident progenitors labeled with Top2a responsible for proximal tubular regeneration in ischemia reperfusion-induced acute kidney injury. Cell Signal. 2023;101:110506.","DOI":"10.1016\/j.cellsig.2022.110506"},{"key":"128","doi-asserted-by":"crossref","unstructured":"Lee J, Park J, Hur Y, Um D, Choi HS, Park J, Kim Y, Lee JS, Choi K, Kim E, Park YB, Choi JM, Kim TK, Lee Y. ETV5 reduces androgen receptor expression and induces neural stem-like properties during neuroendocrine prostate cancer development. Proc Natl Acad Sci U S A. 2025;122:e2420313122.","DOI":"10.1073\/pnas.2420313122"},{"key":"129","doi-asserted-by":"crossref","unstructured":"Burslem GM, Crews CM. Proteolysis-targeting chimeras as therapeutics and tools for biological discovery. Cell. 2020;181:102-14.","DOI":"10.1016\/j.cell.2019.11.031"},{"key":"130","doi-asserted-by":"crossref","unstructured":"Hagopian G, Grant C, Nagasaka M. Proteolysis targeting chimeras in non-small cell lung cancer. Cancer Treat Rev. 2023;117:102561.","DOI":"10.1016\/j.ctrv.2023.102561"}],"container-title":["Critical Reviews\u2122 in Oncogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dl.begellhouse.com\/download\/article\/668e4ab0774498da\/CRO-60912.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T11:30:03Z","timestamp":1769945403000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dl.begellhouse.com\/journals\/439f422d0783386a,5ef47b5e5756d54d,668e4ab0774498da.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":129,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1615\/critrevoncog.2025060912","relation":{},"ISSN":["0893-9675"],"issn-type":[{"value":"0893-9675","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]}}}